US Patent 8980879 Bromodomain inhibitors
Patent 8980879 was granted and assigned to AbbVie Inc. on March, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 22 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+74 characters)
Article
Patent abstract
The present invention provides for compounds of formula (I)
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08980879 Bromodomain inhibitors US Patent 8980879 Bromodomain inhibitors
Infobox
Patent Number
0898087900
Patent Number
898087900
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
089808790
Date of Patent
March 17, 2015
0Patent Application Number
142036510
Date Filed
March 11, 2014
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
089808790
Date of Patent
March 17, 2015
0Patent Application Number
142036510
Date Filed
March 11, 2014
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 29 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 08980879 Bromodomain inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
08980879
Date of patent
March 17, 2015
Patent application number
14203651
Date Filed
March 11, 2014
Patent primary examiner
Find more entities like US Patent 8980879 Bromodomain inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
